Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells

PLoS ONE

Volumn 2, Issue 4, 2007, Pages

  Nawroth, Roman ^a,b   van Zante, Annemieke ^c   Cervantes, Sara ^a   McManus, Michael ^a   Hebrok, Matthias ^a,d   Rosen, Steven D ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; SULFATASE; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ADENOCARCINOMA; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; DNA MICROARRAY; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

MUS;

ADENOCARCINOMA; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE SILENCING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; SULFATASES; UP-REGULATION; WNT PROTEINS;

EID: 55349119506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000392     Document Type: Article

References (50)

1. Laheru D, Jaffee EM (2005) Immunotherapy for pancreatic cancer - science driving clinical progress. Nat Rev Cancer 5: 459-467.
2. Pasca di Magliano M, Hebrok M (2003) Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 3: 903-911.
3. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434: 843-850.
4. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gersteriblith MR, et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851.
5. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856.
6. Nusse R, Various HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109.
7. Balico A, Liu G, Goldin L, Harris V, Aaronson SA (2004) An autocrine mechanism for constitutive Writ pathway activation in human cancer cells. Cancer Cell 6: 497-506.
8. Derksen PW, Tjin E, Meijer HP, Klok MD, MacGillavry HD, et al. (2004) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci U S A 101: 6122-6127.
9. Zeng G, Germinaro M, Micsenyi A, Monga. NK, Bell A, et al. (2006) Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8: 279-289.
10. Lowy AM, Fenoglio-Preiser C, Kim OJ, Kordich J, Gomez A, et al. (2003) Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann Surg Oncol 10: 284-290.
11. Chada S, Bocangel D, Ramesh R, Grimm EA, Mumm JB, et al. (2005) mda-7/ IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer. Mol Ther 11: 724-733.
12. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634.
13. Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131: 6009-6021.
14. Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, et al. (2000) Syndecan- 1 is required for Wnt- 1 -induced mammary tumorigenesis in mice. Nat Genet 25: 329-332.
15. Capurro MI, Yiang YY, Lobe C, Filmus J (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 65: 6245-6254.
16. Esko JD, Lindahl U (2001) Molecular diversity of heparan sulfate. J Clin Invest 108: 169-173.
17. Gallagher JT (2001) Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108: 357-361.
18. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, et al. (2006) HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem 7: 2.
19. Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, et al. (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162: 341-351.
20. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, et al. (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293: 1663-1666.
21. Ohio T, Uchida H, Yamazaki H, Keino-Masu K, Matsui A, et al. (2002) Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage. Genes Cells 7: 173-185.
22. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277: 49175-49185.
23. Viviano BL, Paine-Saunders S, Gasiunas N, Gallagher J, Saunders S (2003) Domain specific modification of HS by Qsulfl modulates the binding of the BMP antagonist Noggin. J Biol Chem 279: 5604-5611.
24. Kakinuma Y, Saito F, Ohsawa S, Furuichi T, Miura M (2004) A sulfatase regulating the migratory potency of oligodendrocyte progenitor cells through tyrosine phosphorylation of beta-catenin. J Neurosci Res 77: 653-661.
25. Morimoto-Tomita M, Uchimura K, Bistrup A, Lum DH, Egeblad M, et al. (2005) Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia 7: 1001-1010.
26. Lamanna WC, Baldwin RJ, Padva. M, Kalus I, Ten Dam G, et al. (2006) Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional cooperativity. Biochem J 400: 63-73.
27. Lum DH, Tan JH, Rosen SD, Werb Z (2006) Gene trap disruption of the mouse heparan sulfate 6-O enclosulfatase, Sulf2. Mol Cell Biol 27: 678-688.
28. Lai J, Chien J, Staub J, Avula R, Greene EL, et al. (2003) Loss of HSulf-1 upregulates heparin-binding growth factor signaling in cancer. J Biel Chem 278: 23107-23117.
29. Lai JP, Chien J, Strome SE, Staub J, Montoya DIP, et al. (2004) HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 23: 1439-1447.
30. Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, et al. (2004) hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing hepayin-binding growth factor signaling. Gastroenterology 126: 231-248.
31. Li J, Kleeff J, Abiatari I, Kayed H, Giese NA, et al. (2005) Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer. Mot Cancer 4: 14.
32. Dai Y, Yang Y, MacLeod V, Yoe X, Rapraeger AC, et al. (2005) HSulf-1 and HSulf-2 are potent inhibitors of niyeloma tumor growth in vivo. J Biol Chem 280: 40065-40073.
33. Lai JP, Yu C, Moser CD, Aderca I, Han T, et al. (2006) SULF1 inhibits tumor growth and potentiates the effects of historic deacetylase inhibitors in hepatocedular carcinoma. Gastroenterology 130: 2130-2144.
34. Narita K, Staub J, Chien J, Meyer K, Bauer M, et al. (2006) HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res 66: 6025-6032.
35. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, et al. (2003) Expression of Wnt, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr 11: 141-147.
36. Gatti LM, Barnes T, Cheng T, Acosta L, Anglade A, et al. (2006) Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3. Dev Dyn 235: 681-690.
37. Kreuger J, Salmivirta M, Sturiale L, Gimenez-Gallego G, Lindahl U (2001) Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 276: 30744-30752.
38. Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, et al. (2006) Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res 8: R56.
39. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, et al. (2003) Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162: 1151-1162.
40. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, et al. (2001) Classification of human lung carcinomas by mRNA expression profiting reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98: 13790-13795.
41. Morimoto-Tomita MU, Kenji;Rosen, Steven D (2003) Novel extracellular sulfatases: potential roles in cancer. Trends in Glycosciences and Glycotechnology 15: 159-164.
42. Marcao A, Azevedo JE, Gieselmann V, Sa Miranda MC (2003) Oligomerization capacity of two arylsulfatase A mutants: C300F and P425T. Biochem Biophys Res Commun 306: 293-297.
43. Ai X, Do AT, Kusche-Gubberg M, Lindahl U, Lu K, et al. (2006) Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulF1 and QSulf2. J Biol Chem 281: 4969-4976.
44. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7: 469-483.
45. He B, Lee AY, Dadfarmay S, You L, Xu Z, et al. (2005) Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res 65: 743-748.
46. Mazieres J, He B, You L, Xu Z, Lee AY, et al. (2004) Writ inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer, Cancer Res 64: 4717-4720.
47. You L, He B, Xu Z, Uernatsu K, Mazieres J, et al. (2004) Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23: 6170-6174.
48. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, et al. (2004) Crelox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A 101: 10380-10385.
49. Wiznerowicz M, Trono D (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77: 8957-8961.
50. So AI, Welsh JB, Sapinciso LM, Kern SG, Dimitrov P, et al. (2001) Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61: 7388-7393.